Skip to main content

Good evening,

Join the Globe’s health columnist André Picard and deputy national editor Nicole MacIntyre for a Facebook Live discussion on COVID-19 vaccines on Thursday, April 1 at 2 p.m. Send us your questions. Get a reminder on Facebook.

Here are the coronavirus updates you need to know tonight.

Top headlines:

  1. Canada’s National Advisory Committee on Immunization recommended pausing AstraZeneca’s vaccine for people under the age of 55. Here’s what you need to know
  2. A nearly 50-50 split of public/private investment in an influenza vaccine manufacturing facility in Toronto will ensure Canada has the capability to produce enough doses for the entire population, according to a government official
  3. Alberta is warning that the province is seeing cases of COVID-19 transmission outside – believed to be driven by the variants

In the last 7 days, 35,747 cases were reported, up 32 per cent from the previous 7 days. There were 200 deaths announced, down 2 per cent over the same period. At least 2,433 people are being treated in hospitals and 911,296 others are considered recovered.

Canada’s inoculation rate is 34th among 84 countries with a population of one million or more people.

Sources: Canada data is compiled from government websites, Johns Hopkins and COVID-19 Canada Open Data Working Group; international data is from Johns Hopkins University.


Coronavirus explainers: Coronavirus in maps and chartsTracking vaccine dosesLockdown rules and reopeningVaccine distribution planFour vaccines approved in CanadaEssential resources


Photo of the day

Catholic faithfuls watch as the traditional Nazareno de San Pablo (Saint Paul's Nazarene) procession was carried out on a 'Popemobile' vehicle through Caracas as a measure to avoid large gatherings of people amid the pandemic.PEDRO RANCES MATTEY/AFP/Getty Images


Coronavirus in Canada


In Ottawa, the federal government announced an almost billion-dollar investment to build an “end-to-end” influenza vaccine manufacturing facility. Funding for the project will be split almost 50-50 between Ottawa, Ontario and pharmaceutical giant Sanofi.

  • The project will ensure that Canada has an operational domestic vaccine manufacturing plant by 2026 that can make enough vaccines for the entire population within about six months of the World Health Organization identifying a pandemic flu strain, the federal government said Wednesday.
  • Sanofi will spend $455-million on the facility, the federal government is pledging $415-million and Ontario will kick-in $50-million. The facility will be used to make Sanofi’s Fluzone vaccine, a high-dose quadrivalent influenza shot.

COVID-19 vaccines


Coronavirus around the world


Coronavirus and business

Canada’s real gross domestic product rose 0.7 per cent in January, outrunning a previous estimate of 0.5 per cent, Statistics Canada said today.

  • That leaves economic activity about 2.6 per cent lower than it was pre-pandemic. A further 0.5-per-cent expansion is estimated for February.

Also today: Canada’s Parliamentary Budget Officer projected a federal deficit of $363.4-billion, and questioned the need for $100-billion stimulus.

And: The World Trade Organization has raised its 2021 global trade growth outlook, but says COVID-19 remains a risk.


Globe opinion


More reporting


Information centre

Sources: Canada data are compiled from government websites, Johns Hopkins University and COVID-19 Canada Open Data Working Group; international data are from Johns Hopkins.

What are we missing? Email us: audience@globeandmail.com. Do you know someone who needs this newsletter? Send them to our Newsletters page.